TEVA PHARMACEUTICAL INDUSTRIES LIMITED Long-Term Debt, Maturity, after Year Five
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) had Long-Term Debt, Maturity, after Year Five of $14.68 billion as of 2017-12-31, per its 10-K filed 2018-02-12.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive · last filed 2018-02-12
- 2017-12-31: Long-Term Debt, Maturity, after Year Five $14.68B.
- 2016-12-31: Long-Term Debt, Maturity, after Year Five $15.25B.
- 2015-12-31: Long-Term Debt, Maturity, after Year Five $5.00B.
- 2014-12-31: Long-Term Debt, Maturity, after Year Five $4.72B.
| Period end | Long-Term Debt, Maturity, after Year Five |
|---|---|
| 2017-12-31 | $14.68B 10-K · filed 2018-02-12 |
| 2016-12-31 | $15.25B 20-F · filed 2017-02-15 |
| 2015-12-31 | $5.00B 20-F · filed 2016-02-11 |
| 2014-12-31 | $4.72B 20-F · filed 2015-02-09 |
| 2013-12-31 | $6.55B 20-F · filed 2014-02-10 |
| 2012-12-31 | $7.03B 20-F · filed 2013-02-12 |
| 2011-12-31 | $2.89B 20-F · filed 2012-02-17 |
| 2010-12-31 | $1.51B 20-F · filed 2011-02-15 |